These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 710453)

  • 1. Steroid-CPK test. A new diagnostic aid for muscular dystrophy and its carriers?
    Sen S; Das PK
    Eur Neurol; 1978; 17(5):258-64. PubMed ID: 710453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in female relatives and patients with X-linked muscular dystrophies (Duchenne and Becker).
    Zatz M; Shapiro LJ; Campion DS; Kaback MM; Otto PA
    J Neurol Sci; 1980 Jun; 46(3):267-79. PubMed ID: 7381516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of young female carriers of Duchenne muscular dystrophy].
    Alvarez Leal MA; Morales-Aguilera A
    Arch Invest Med (Mex); 1990; 21(3):269-72. PubMed ID: 2131776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum creatine phosphokinase and pyruvate kinase in neuromuscular disorders and Duchenne dystrophy carriers.
    Seay AR; Ziter FA; Wu LH; Wu JT
    Neurology; 1978 Oct; 28(10):1047-50. PubMed ID: 570660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and genetic counselling of subclinical and carrier states in Duchenne muscular dystrophy.
    Das PK; Sen SK
    Eur Neurol; 1979; 18(2):91-5. PubMed ID: 456392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier detection in Duchenne muscular dystrophy. Evidence from a study of obligatory carriers and mothers of isolated cases.
    Sibert JR; Harper PS; Thompson RJ; Newcombe RG
    Arch Dis Child; 1979 Jul; 54(7):534-7. PubMed ID: 485196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of serum creatine phosphokinase to steroid hormone.
    Takahashi K; Oimomi M; Shinko T; Shutta K; Matsuo B
    Arch Neurol; 1975 Feb; 32(2):89-91. PubMed ID: 1122183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Critical evaluation of changes of serum CK after exertion in the identification of carriers of Duchenne's muscular dystrophy].
    Cordone G; Venzano V; Rossi G; Cavallero G; Minetti C
    Pediatr Med Chir; 1984; 6(6):819-22. PubMed ID: 6545595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of concomitant serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) for carrier detection in Duchenne's muscular dystrophy through discriminant analysis.
    Zatz M; Otto PA
    J Neurol Sci; 1980 Sep; 47(3):411-7. PubMed ID: 7420115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid-induced CPK estimation--a new diagnostic test for human muscular dystrophy and its carrier state.
    Sen S; Das PK
    Arch Dis Child; 1978 Jun; 53(6):521-2. PubMed ID: 686785
    [No Abstract]   [Full Text] [Related]  

  • 11. Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study.
    Zatz M; Frota-Pessoa O; Levy JA; Peres CA
    J Genet Hum; 1976 Jun; 24(2):153-68. PubMed ID: 965952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum creatine kinase isoenzymes in Duchenne muscular dystrophy determined by sensitive enzyme immunoassay methods.
    Mokuno K; Riku S; Sugimura K; Takahashi A; Kato K; Osugi S
    Muscle Nerve; 1987 Jun; 10(5):459-63. PubMed ID: 3302699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in progressive muscular dystrophies.
    Zatz M; Shapiro LJ; Campion DS; Oda E; Kaback MM
    J Neurol Sci; 1978 May; 36(3):349-62. PubMed ID: 681967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection.
    Percy ME; Chang LS; Murphy EG; Oss I; Verellen-Dumoulin C; Thompson MW
    Muscle Nerve; 1979; 2(5):329-39. PubMed ID: 492209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of preclinical Duchenne muscular dystrophy and its female carriers.
    Beckmann R
    Isr J Med Sci; 1977 Feb; 13(2):102-6. PubMed ID: 863671
    [No Abstract]   [Full Text] [Related]  

  • 16. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
    Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the activity of creatine phosphokinase for the detection of carriers of Duchenne-type muscular dystrophy in families in the city of Monterrey, Mexico].
    Alvarez Leal M; Ortiz Mariscal JD; Narro Juárez A; Solís Alanís JG; Morales Aguilera A
    Rev Invest Clin; 1990; 42(1):39-45. PubMed ID: 2236973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new method for the analysis of age trends in CPK levels with application to Duchenne muscular dystrophy.
    Lange K; Zatz M
    Hum Hered; 1979; 29(3):154-60. PubMed ID: 468274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of carriers of X-linked gene for Duchenne muscular dystrophy by levels of creatine kinase and pyruvate kinase.
    Falcão-Conceição DN; Gonçalves-Pimentel MM; Baptista ML; Ubatuba S
    J Neurol Sci; 1983 Dec; 62(1-3):171-80. PubMed ID: 6668472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of hydrocortisone on the serum creatine kinase activity of muscles diseases.
    Cxyzewski K
    J Neurol; 1977 Nov; 216(4):283-7. PubMed ID: 72811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.